» Articles » PMID: 21309500

The Frequency of HLA Class I and II Alleles in Turkish Childhood Acute Leukaemia Patients

Overview
Journal J Int Med Res
Publisher Sage Publications
Specialty General Medicine
Date 2011 Feb 12
PMID 21309500
Citations 9
Authors
Affiliations
Soon will be listed here.
Abstract

In this study, blood samples were taken from 200 patients with childhood acute leukaemias, including acute lymphoblastic leukaemia (ALL) and acute myeloid leukaemia (AML), and from 100 healthy volunteers (controls). The frequency of the human leucocyte antigen (HLA)-DRB1*04 allele was significantly higher, and the frequencies of the HLA-A23 and HLA-B7 antigens were significantly lower, in patients with ALL compared with controls. Among patients with AML, the frequency of the HLA-B49 antigen and the HLA-DRB1*15 allele were significantly higher, whereas the frequencies of the HLA-A11 and HLA-B38 antigens were significantly lower compared with controls. The frequency of the HLA-DRB1*04 allele was also significantly higher in male patients with ALL and AML, whereas the HLA-DRB1*13 allele was found significantly less frequently in male AML and female ALL patients than in controls. To date, this is the only study to evaluate the associations between HLA molecules and leukaemia in a Turkish population with acute childhood leukaemia.

Citing Articles

Human Leukocyte Antigen Alleles (HLA-A, HLA-B, and HLA-DRB1) are associated with Acute Lymphoblastic Leukemia (ALL) : A Case-Control Study in a Sample of Iranian Population.

Kohansal Vajari M, Ehsan M, Ghiasi S, Fooladi S, Karami N, Hassanshahi G Asian Pac J Cancer Prev. 2024; 25(5):1507-1513.

PMID: 38809622 PMC: 11318837. DOI: 10.31557/APJCP.2024.25.5.1507.


The association of HLA-DRB1 alleles and MBL2 gene variant in pediatric acute lymphoblastic leukemia patients.

Oguz R, Senturk Ciftci H, Gokce M, Ogret Y, Karadeniz S, Pehlivan S Hematol Transfus Cell Ther. 2023; 46(4):327-334.

PMID: 37117150 PMC: 11451356. DOI: 10.1016/j.htct.2023.02.002.


Frequency of HLA alleles and KIR Ligands in Acute Myeloid Leukemia in Indian Cohort.

DSilva S, Bodade A, Kadam S, Tambe M, Dhanda S, Bagal B Indian J Hematol Blood Transfus. 2023; 39(1):50-56.

PMID: 36699439 PMC: 9868221. DOI: 10.1007/s12288-022-01550-0.


The Frequency of HLA-A, HLA-B, and HLA-DRB1 Alleles in Patients with Acute Lymphoblastic Leukemia in the Turkish Population: A Case-Control Study.

Patiroglu T, Akar H Turk J Haematol. 2016; 33(4):339-345.

PMID: 27095065 PMC: 5204191. DOI: 10.4274/tjh.2016.0102.


Altered HLA Class I Profile Associated with Type A/D Nucleophosmin Mutation Points to Possible Anti-Nucleophosmin Immune Response in Acute Myeloid Leukemia.

Kuzelova K, Brodska B, Fuchs O, Dobrovolna M, Soukup P, Cetkovsky P PLoS One. 2015; 10(5):e0127637.

PMID: 25992555 PMC: 4439052. DOI: 10.1371/journal.pone.0127637.